Richter J
Department of Medicine, University Hospital, Lund, Sweden.
J Leukoc Biol. 1992 Mar;51(3):270-5. doi: 10.1002/jlb.51.3.270.
Adenosine and adenosine analogues are potent inhibitors of the respiratory burst in neutrophils. Most investigators, however, have found little or no effect of these compounds on neutrophil degranulation from cytochalasin B-treated neutrophils in suspension. We have instead investigated the effect of adenosine and 2-chloroadenosine on degranulation in adherent neutrophils in the absence of cytochalasin B. Both adenosine and 2-chloroadenosine were effective inhibitors of lactoferrin secretion induced by the chemotactic peptide N-formyl-methionine-leucyl-phenylalanine (fMLP) [50% inhibitory concentration (IC50) of less than 10(-6) M]. Secretion induced by tumor necrosis factor (TNF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) was inhibited only at high concentrations (IC50 of approximately 10(-4) M). In the presence of cytochalasin B no inhibitory effect of 2-chloroadenosine was seen. The effect of cAMP-raising agents on secretion from adherent neutrophils was also investigated. Dibutyryl cAMP at 0.2 mM reduced secretion in response to fMLP by 50% but did not inhibit TNF- and GM-CSF-induced degranulation. At a concentration of 2.0 mM dibutyryl cAMP also inhibited exocytosis in response to the two cytokines. The phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) at 300 microM reduced fMLP-induced degranulation, whereas a concentration of 1 mM was required to inhibit TNF- and GM-CSF-mediated secretion. The adenylate cyclase activator forskolin (50 microM) alone did not inhibit secretion in response to TNF or fMLP. However, in combination with IBMX (300 microM), forskolin (50 microM) reduced both TNF- and fMLP-induced secretion to less than 10%. PMA-induced exocytosis was unaffected by all these agents. In conclusion, adenosine appears to be an effective inhibitor of neutrophil granule protein secretion induced by fMLP but only a weak inhibitor of exocytosis in response to TNF or GM-CSF. Secretion in response to fMLP was also found to be more susceptible to a rise in cAMP than degranulation induced by TNF and GM-CSF.
腺苷及腺苷类似物是中性粒细胞呼吸爆发的强效抑制剂。然而,大多数研究人员发现,这些化合物对悬浮状态下经细胞松弛素B处理的中性粒细胞的脱颗粒作用很小或没有作用。相反,我们研究了在不存在细胞松弛素B的情况下,腺苷和2-氯腺苷对贴壁中性粒细胞脱颗粒的影响。腺苷和2-氯腺苷都是趋化肽N-甲酰甲硫氨酰-亮氨酰-苯丙氨酸(fMLP)诱导的乳铁蛋白分泌的有效抑制剂[半数抑制浓度(IC50)小于10^(-6) M]。肿瘤坏死因子(TNF)或粒细胞-巨噬细胞集落刺激因子(GM-CSF)诱导的分泌仅在高浓度时受到抑制(IC50约为10^(-4) M)。在存在细胞松弛素B的情况下,未观察到2-氯腺苷的抑制作用。还研究了提高cAMP的试剂对贴壁中性粒细胞分泌的影响。0.2 mM的二丁酰cAMP使fMLP诱导的分泌减少50%,但不抑制TNF和GM-CSF诱导的脱颗粒。在2.0 mM的浓度下,二丁酰cAMP也抑制了对这两种细胞因子的胞吐作用。300 μM的磷酸二酯酶抑制剂3-异丁基-1-甲基黄嘌呤(IBMX)减少了fMLP诱导的脱颗粒,而抑制TNF和GM-CSF介导的分泌需要1 mM的浓度。腺苷酸环化酶激活剂福斯高林(50 μM)单独使用时不抑制TNF或fMLP诱导的分泌。然而,与IBMX(300 μM)联合使用时,福斯高林(50 μM)将TNF和fMLP诱导的分泌均降低至10%以下。佛波酯(PMA)诱导的胞吐作用不受所有这些试剂的影响。总之,腺苷似乎是fMLP诱导的中性粒细胞颗粒蛋白分泌的有效抑制剂,但对TNF或GM-CSF诱导的胞吐作用只是一种弱抑制剂。还发现,与TNF和GM-CSF诱导的脱颗粒相比,fMLP诱导的分泌对cAMP升高更敏感。